A pilot study marshals sequencing resources and broad expertise to analyze patients' tumors in a cost-effective and clinically relevant time frame.
No takes yet. Share an insight, caveat, or question.
Christopher L. Corless (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: